Brief Description
Catalyst is a clinical-stage biopharmaceutical company leveraging exceptional science to discover and develop essential medicines. Catalyst is focused on creating and commercializing novel medicines to address serious medical conditions for patients who need new or better treatment options.
Timeline
- 2002. Company founded
- 2015. Company merged, acquiring Targacept through a reverse merger, resulting in the combined entity trading on the NASDAQ under the ticker symbol CBIO
- 2023. Merges with, and changes name to, Gyre Therapeutics, trading stock on NASDAQ under the ticker symbol GYRE
Inventors
Bradley Backes, Charles Craik, Jonathan Ellman, Jennifer Harris